Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v2-FR
Language English French
Date Updated 2019-11-08 2019-08-29
Drug Identification Number 02275058 02275058
Brand name TEVA-VENLAFAXINE XR TEVA-VENLAFAXINE XR
Common or Proper name VENLAFAXINE VENLAFAXINE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients VENLAFAXINE VENLAFAXINE
Strength(s) 150MG 150MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 500 500
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-28 2019-08-28
Estimated end date 2019-12-31 2019-09-30
Actual end date 2019-11-07
Shortage status Resolved Actual shortage
Company comments
Health Canada comments